A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject

• Status: Completed
• Trial end date: 2008-05-05
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb

Criteria

Inclusion Criteria:

• Healthy male subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations

• Body Mass Index (BMI) of 18 to 30 kilogram / square meter (kg/m2), inclusive

• Signed informed consent

Exclusion Criteria:

• Women

• Any significant acute or chronic medical illness

• Current or recent (within 3 months) gastrointestinal disease including peptic ulcer

Other protocol inclusion/exclusion criteria may apply